Clinical Trial Update: Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating a three-drug regimen (daratumumab, ixazomib, and dexamethasone) for AL amyloidosis; the study is currently active an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• NINLARO (ixazomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING